MARKET

CATX

CATX

Perspective Therapeutics Inc
AMEX
2.910
-0.040
-1.36%
After Hours: 2.960 +0.05 +1.72% 19:47 07/24 EDT
OPEN
2.970
PREV CLOSE
2.950
HIGH
3.000
LOW
2.900
VOLUME
671.33K
TURNOVER
--
52 WEEK HIGH
6.16
52 WEEK LOW
1.955
MARKET CAP
331.87M
P/E (TTM)
-2.0845
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CATX last week (0713-0717)?
Weekly Report · 5d ago
As Q2 earnings kick off, these small-cap stocks earn an A+ for profitability
Seeking Alpha · 07/17 17:06
Perspective Therapeutics' Updated Data On Its [212Pb]VMT-α-NET Program Accepted For Presentation At European Society Of Medical Oncology Congress 2026
Benzinga · 07/17 16:24
Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Benzinga · 07/14 12:03
Weekly Report: what happened at CATX last week (0706-0710)?
Weekly Report · 07/13 09:38
Perspective Therapeutics management to meet virtually with BTIG
TipRanks · 07/10 17:55
Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and Tenaya Therapeutics (TNYA)
TipRanks · 07/06 11:20
Weekly Report: what happened at CATX last week (0629-0703)?
Weekly Report · 07/06 09:40
More
About CATX
Perspective Therapeutics, Inc. is a radiopharmaceutical development company that is developing advanced treatment applications for cancers throughout the body. The Company has proprietary technology that utilizes the alpha-emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties. It is also developing imaging diagnostics that incorporate the same targeting moieties, which provide the opportunity to personalize treatment and optimize patient outcomes. This theranostic approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity. The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs have entered Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at several academic institutions. It has also developed a 212Pb generator to secure key isotopes for clinical trial and commercial operations.

Webull offers Perspective Therapeutics Inc stock information, including AMEX: CATX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CATX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CATX stock methods without spending real money on the virtual paper trading platform.